Table 2.

Association between serum TG/HDL-C and the incidence of T2DM in the REACTION study.

	Crude	Model I	Model II
TG/HDL-C	1.78 (1.53–2.06) <0.01	1.60 (1.37–1.87) <0.01	1.49 (1.26–1.78) <0.01
TG/HDL-C quintile
Q1	1	1	1
Q2	1.53 (0.98–2.39) 0.06	1.36 (0.87–2.13) 0.17	1.34 (0.82–2.20) 0.24
Q3	1.98 (1.29–3.03) <0.01	1.66 (1.08–2.55) 0.02	1.55 (0.96–2.51) 0.07
Q4	2.94 (1.96–4.39) <0.01	2.32 (1.53–3.50) <0.01	2.23 (1.41–3.53) <0.01
Q5	3.71 (2.51–5.51) <0.01	2.88 (1.92–4.31) <0.01	2.42 (1.53–3.84) <0.01
P for trend	<0.01	<0.01	<0.01

Data are ORs (95% CI). Model I was adjusted for age, sex, and body mass index. Model II was adjusted for the variables in model I plus histories of hypertension, tumors, stroke, and coronary heart disease, smoking status, alcohol intake, low-density lipoprotein cholesterol level, strenuous activity, education level, and family histories of T2DM and tumors.